Skip to content
Disclosery

EXANE DERIVATIVES: EWZ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on EWZ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 31 EWZ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 31 shares
    Change vs previous 13F -5 shares

    <0.01% of the 13F portfolio, value $849.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 36 shares
    Change vs previous 13F -54,124 shares

    <0.01% of the 13F portfolio, value $1,361.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 54,160 shares
    Change vs previous 13F +2,864 shares

    0.37% of the 13F portfolio, value $1,520,195.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 51,296 shares
    Change vs previous 13F +10,130 shares

    0.41% of the 13F portfolio, value $1,648,059.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 41,166 shares
    Change vs previous 13F -6,765 shares

    0.38% of the 13F portfolio, value $1,623,125.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 47,931 shares
    Change vs previous 13F +4,645 shares

    0.48% of the 13F portfolio, value $1,603,195.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 43,286 shares
    Change vs previous 13F +4,147 shares

    0.49% of the 13F portfolio, value $1,604,511.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 39,139 shares
    Change vs previous 13F not available

    0.35% of the 13F portfolio, value $1,082,540.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).